ResMed Inc (RMD)

Days of sales outstanding (DSO)

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Receivables turnover 5.48 5.34 5.13 5.93 5.43 5.70 5.98 6.12 5.99 5.85 5.60 5.84 6.21 6.96 6.55 5.82 5.20 5.89 6.07 6.51
DSO days 66.63 68.29 71.10 61.59 67.22 63.99 61.02 59.66 60.93 62.38 65.20 62.49 58.75 52.45 55.75 62.73 70.14 61.99 60.13 56.04

June 30, 2025 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.48
= 66.63

The analysis of ResMed Inc.'s days of sales outstanding (DSO) over the specified period reflects a generally upward trend with fluctuations. Starting at approximately 56.04 days as of September 30, 2020, the DSO increased to a peak of around 70.14 days by June 30, 2021. This period indicates a lengthening of the receivables collection cycle, suggesting potential challenges in collection efficiency or changes in credit terms during that interval.

Subsequently, the DSO decreased to a low of roughly 52.45 days as of March 31, 2022, implying an improvement in receivables management and possibly more stringent credit controls or faster collections. However, the trend reversed after this point, as DSO values gradually increased again, reaching approximately 65.20 days by December 2022 and fluctuating thereafter.

From late 2022 onward, the DSO remained elevated relative to pre-2021 levels, with values often exceeding 60 days. Notably, the DSO jumped to approximately 71.10 days as of December 2024, representing the highest figure within the dataset. The latest recorded figure of 68.29 days as of March 2025 indicates some partial stabilization but still reflects a comparatively prolonged collection cycle.

Overall, the data suggests that ResMed Inc. experienced periods of receivables collection inefficiency, with notable increases during certain intervals, particularly after 2021. These fluctuations could be attributable to changes in customer credit policies, economic conditions, industry-specific challenges, or strategic shifts in credit management. A persistently elevated DSO may impact cash flow and liquidity, warranting further analysis into collection practices and credit risk management to understand underlying causes and mitigate potential financial strain.